abstract |
The invention relates to a dual-, sustained-, delayed-, controlled- ornpulsed-release pharmaceutical composition for the prevention ofnmigraine recurrence comprising a 5-HT 1B/1D receptor agonist, or anpharmaceutically acceptable salt thereof, and a pharmaceuticallynacceptable excipient, diluent or carrier. |